Omeros | OMER - DEBITO





DEBITO Cambiamento Data
Adma Biologics USD 83.12M 702K 2025-09
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
BioMarin Pharmaceutical USD 605.86M 1.62M 2025-12
Cytokinetics USD 1.28B 87.39M 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Insmed USD 727.89M 163.33M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.96B 3.11B 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 2.03B 195.7M 2025-12
Xoma USD 120.79M 3.27M 2024-06